Journals / Türk Geriatri Dergisi / 2014 / Cilt: 17 - Sayı: 4

DİYABETİK OLMAYAN YAŞLI BİR HASTADA SİPROFLOKSASİNİN NEDEN OLDUĞU HİPOGLİSEMİ: BİR VAKA SUNUMU

HYPOGLYCEMIA CAUSED BY CIPROFLOXACIN IN A NON-DIABETIC ELDERLY PATIENT: A CASE REPORT

Pages
426–429
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, drug-related causes should be considered in cases of unexplained hypoglycemia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fluoroquinolones, a commonly used class of antibiotics, can impair glucose homeostasis.
📊
Key Findings & Data:An 80-year-old female patient was admitted to the emergency department with hypoglycemia.
💡
Conclusion & Impact:Moreover, drug-related causes should be considered in cases of unexplained hypoglycemia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Fluoroquinolones, a commonly used class of antibiotics, can impair glucose homeostasis. Hypoglycemia may be life-threatening in non-diabetic elderly patients with renal impairment. An 80-year-old female patient was admitted to the emergency department with hypoglycemia. The patient was not a diabetic and did not use antidiabetic drugs. Three days prior, she had received ciprofloxacin for a urinary tract infection. During hypoglycemic process, her insulin level was not suppressed. At follow-up in inpatient service, her insulin level had returned to the normal range. Her serum cortisol level was normal, and pancreatic imaging was normal. After ciprofloxacin was discontinued, no further hypoglycemic episodes occurred. Physicians should be careful in prescribing fluoroquinolones in older patients who are prone to hypoglycemia. Moreover, drug-related causes should be considered in cases of unexplained hypoglycemia.

Özet

Antibiyotiklerin yaygın olarak kullanılan bir sınıfı olan florokinolonlar, glukoz dengesini bozabilir. Böbrek yetersizliği olan non-diyabetik yaşlılarda florokinolon kullanımında (özellikle siprofloksasin)hipoglisemi hayatı tehdit edici olabilir. Seksen yaşında kadın hasta acil birimine hipoglisemi ile başvurdu. Hasta diyabetik değildi ve antidiyabetik ilaç kullanmıyordu. Üç gün önce idrar yolu enfeksiyonu için siprofloksasin almıştı. Hipoglisemik süreç boyunca hastanın insülin düzeyi baskılanmadı. Hastanın yatan hasta servisinde yapılan takiplerinde insülin düzeyi normal aralığa döndü. Serum kortizol düzeyi normaldi, ve pankreas görüntülemesi normaldi. Siprofloksasin kesildikten sonra başka hipoglisemi atakları olmadı. Doktorlar hipoglisemiye meyilli olan yaşlı hastalaraflorokinolon reçete ederken dikkatli olmaları gerekir. Ayrıca, açıklanamayan hipoglisemi durumlarında ilaç-ilişkili nedenler akla gelmelidir.

🔖

Cite This Article

ARPACI, D., TOÇOLU, A. G., AÇIKGÖZ, B. S., TAMER, A. (2022). DİYABETİK OLMAYAN YAŞLI BİR HASTADA SİPROFLOKSASİNİN NEDEN OLDUĞU HİPOGLİSEMİ: BİR VAKA SUNUMU. Türk Geriatri Dergisi, Cilt: 17 - Sayı: 4, 426–429. https://ajindex.com/articles/623915

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Friedrich LV, Dougherty R. Fatal hypoglycemia associated with lev- ofloxacin. Pharmacotherapy 2004
  2. (PMID:15585448). Rubinstein E. History of quinolones and their side effects. Chemotherapy 2001
  3. 47(Suppl 3:3-8):44-8. (PMID:11549783). Rodvold KA, Piscitelli SC. New oral macrolide and fluoro- quinolone antibiotics: an overview of pharmacokinetics, inter- actions, and safety. Clin Infect Dis 1993
  4. 17 (Suppl 1):S192-9. (PMID:8399914). Ball P. New antibiotics for community acquired lower respira- tory tract infections: improved activity at a cost? Int J Antimicrob Agents.2000
  5. (PMID:11091046). Frothingham R. Glucose homeostasis abnormalities associated with the use of gatifloxacin. Clin Infect Dis 2005
  6. (PMID:16206101). Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gat- ifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006
  7. (PMID:16510739). Ahmad SR. Adverse Drug Event Monitoring at the Food and Drug Administration. J Gen Intern Med 2003
  8. 18(1):57-60. (PMID:1494803). Aspinall SL, Good CB, Jiang R, et al. Severe dysglycemia with the fluoroquinolones: A class effect? Clin Infect Dis 2009
  9. 49(3):402-8. (PMID:19545207). Roberge RJ, Kaplan R, Frank P, et al. Glyburide ciprofloxacin interaction with resistant hypoglycaemia. Ann Emerg Med 2000
  10. (PMID:10918110). Menzies DJ, Dorsainvil PA, Cunha BA, et al. Severe and per- sistent hypoglycaemia due to gatifloxacin interaction with oral hypoglycaemic agents. Am J Med 2002
  11. (PMID:12208383). Bhasin R, Arce FC, Pasmantier R. Hypoglycemia associated with the use of gatifloxacin. Am J Med Sci 2005
  12. (PMID:16284487). Parra-Riffo H, Lemus-Penaloza J. Severe levofloxacin-induced hypoglycaemia: A case report and literature review. Nefrologia 2012
  13. (PMID:22806298). Singh N, Jacob JJ. Levofloxacin and hypoglycemia. Clin Infect Dis 2008
  14. 46(7):1127-29. (PMID:18444840). Gibert AE, Porta FS. Hypoglycemia and levofloxacin: A case report. Clin Infect Dis 2008
  15. 46(7):1126-7. (PMID:18444838). Mohr JF, McKinnon PS, Peymann PJ, et al. A retrospective comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin and ceftriax- one. Pharmacotherapy 2005
  16. (PMID:16185173).